Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.53 |
| ▸ | KDM5A | P29375 | 4/20 | 0.53 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.53 |
| ▸ | KDM5C | P41229 | 1/20 | 0.50 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.50 |
| ▸ | KDM4A | O75164 | 2/20 | 0.49 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.48 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 7/20 | 0.46 |
| ▸ | PPARD | Q03181 | 7/20 | 0.46 |
| ▸ | PPARA | Q07869 | 7/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27285975 | 1.00 | KDM4C (0.53) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL7571174 | 1.00 | KDM4C (0.53) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL16040076 | 1.00 | KDM4C (0.53) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL73050 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL5984529 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL448290 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL2802094 | 0.98 | KDM4C (0.51) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL1272817 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL16895244 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL10610457 | 0.98 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1865 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12473379-B2 | Method for obtaining purified bacterial polysaccharides | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2025-11-18 | — | — | US | claimed |
| US-12409175-B2 | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2025-09-09 | — | — | US | claimed |
| CN-115505591-B | Plant oil nucleic acid extraction kit and extraction method | 四川省轻工业研究设计院有限公司 | 2025-01-21 | — | — | CN | claimed |
| US-20240307300-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF AN AQUEOUS OPHTHALMIC SOLUTION OF DIFLUPREDNATE | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED, (IN) | 2024-09-19 | — | — | US | claimed |
| CN-118165982-A | Kit for rapidly extracting RNA and application thereof | 上海麦克林生化科技股份有限公司 | 2024-06-11 | — | — | CN | claimed |
| US-20240180902-A1 | METHOD OF INCREASING BIOAVAILABILITY AND/OR PROLONGING OPHTHALMIC ACTION OF A DRUG | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2024-06-06 | — | — | US | claimed |
| CN-117825688-B | Animal IgG antibody freeze-dried powder preparation and preparation process thereof | 武汉鹰达生物科技有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-117825688-A | Animal IgG antibody freeze-dried powder preparation and preparation process thereof | 武汉鹰达生物科技有限公司 | 2024-04-05 | — | — | CN | claimed |
| US-20240002905-A1 | PATHOGEN INACTIVATING AND NUCLEIC ACID STABILIZATION MEDIA FOR MICROORGANISM COLLECTION AND TRANSPORT | BIOCEPT, INC. (US) | 2024-01-04 | — | — | US | claimed |
| EP-4244236-A1 | PATHOGEN INACTIVATING AND NUCLEIC ACID STABILIZATION MEDIA FOR MICROORGANISM COLLECTION AND TRANSPORT | Biocept, Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| CN-1159159-A | Personal cleansing compositions | PROCTER & GAMBLE (US) | 1997-09-10 | — | — | CN | claimed |
| CN-1159160-A | Thickened nonbarasive personal cleansing compositions | PROCTER & GAMBLE (US) | 1997-09-10 | — | — | CN | claimed |
| US-5441727-A | Controlling malodor from human sweat by including an antimicrobial agent; topical application to skin or clothing | THE PROCTER & GAMBLE COMPANY (US) | 1995-08-15 | — | — | US | claimed |
| EP-0448895-B1 | Use of a non-alcoholic delivery system for active ingredients which are ingested orally | SPECTRUM CONSUMER PROD CO (US) | 1994-05-25 | — | — | EP | claimed |
| EP-0448895-A1 | Use of a non-alcoholic delivery system for active ingredients which are ingested orally | SPECTRUM CONSUMER PRODUCTS CO., INC. (US) | 1991-10-02 | — | — | EP | claimed |
| US-4971785-A | EFFERVESCENT COMPOSITION FOR MOUTHWASHES, COUGH AND COLD REMEDIES, ANTIPYRETICS, ANTACIDS, OTHER DRUGS | SPECTRUM CONSUMER PRODUCTS CO., INC. (US) | 1990-11-20 | — | — | US | claimed |
| US-4919918-A | Non-alcoholic mouthwash | SPECTRUM CONSUMER PRODUCTS CO., INC. (US) | 1990-04-24 | — | — | US | claimed |
| US-4816261-A | Deodorant gel stick | THE PROCTER & GAMBLE COMPANY (US) | 1989-03-28 | — | — | US | claimed |
| US-4569790-A | Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions | CETUS CORPORATION (US) | 1986-02-11 | — | — | US | claimed |
| EP-0156373-A2 | Purified recombinant interleukin-2 and process for recovering and purifying same | CETUS ONCOLOGY CORPORATION (US) | 1985-10-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240307300-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF AN AQUEOUS OPHTHALMIC SOLUTION OF DIFLUPREDNATE | PDE6C, FDPS, QDPR | KDM4C 3574/4885KDM5A 2740/4885PHF8 2136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.